Maxim N Artyomov

52PUBLICATIONS
226CO-AUTHORS
HaematologyPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Information modelling, management and ontologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 04, 2026
CSF1R regulates monocyte subset differentiation and intracellular metabolism.

|Jun 11, 2026
Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancer.

|Apr 17, 2026
Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity.

|Apr 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis.

|Apr 13, 2026
Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging.

Manish Mishra, Hee-Hoon Kim, Yun-Hee Youm

|Apr 10, 2026
Mitochondrial iNOS blocks itaconate production by interacting with IRG1.

Tomas Paulenda, Maxim N Artyomov

Pageof 9

Frequent Collaborators

9 joint publications

Marco Colonna

8 joint publications

Amanda Swain

4 joint publications

Alexey Sergushichev

4 joint publications

Ekaterina Esaulova